A global liver disease, the chronic hepatitis B virus (HBV) infection affects an estimated 257 million people globally. If the virus is not treated, it can result in cirrhosis, liver cancer, and progressive liver damage. The treatment of chronic HBV infection has been revolutionised by antiviral therapy, vastly improving the results for those who are infected.
